Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"15,329 (8,047, 28,353)","72.0% (52.2%, 85.6%)","72.6% (56.8%, 85.6%)","17.0% (10.6%, 27.9%)","69.0% (49.1%, 82.4%)","18.0 (13.0, 21.4)","18.2 (14.2, 21.4)","4.3 (2.6, 7.0)","17.2 (12.3, 20.6)",,,,,
"(p=None, None), q=(None, None), c=0.500)","11,501 (5,954, 23,925)","83.4% (60.7%, 96.7%)","57.0% (38.3%, 76.3%)","12.6% (7.7%, 20.2%)","80.5% (57.4%, 95.1%)","20.8 (15.2, 24.2)","14.3 (9.6, 19.1)","3.1 (1.9, 5.0)","20.1 (14.3, 23.8)","-24.9% (-46.5%, -6.9%)","16.1% (6.2%, 32.9%)","-21.7% (-44.4%, -5.7%)","-24.2% (-57.2%, 3.9%)","17.0% (6.5%, 33.8%)"
"(p=None, None), q=(None, None), c=0.750)","11,616 (6,178, 23,966)","83.7% (60.7%, 97.2%)","56.1% (37.4%, 75.0%)","12.1% (7.4%, 20.2%)","81.1% (57.4%, 96.1%)","20.9 (15.2, 24.3)","14.0 (9.4, 18.7)","3.0 (1.8, 5.1)","20.3 (14.3, 24.0)","-24.0% (-43.3%, -5.7%)","16.5% (5.7%, 33.0%)","-22.9% (-45.2%, -7.1%)","-26.8% (-58.9%, 1.6%)","17.9% (6.2%, 34.7%)"
"(p=None, None), q=(None, None), c=1.000)","11,713 (6,399, 23,586)","84.1% (61.6%, 97.3%)","55.5% (36.9%, 74.9%)","11.7% (7.1%, 18.6%)","81.5% (58.3%, 96.3%)","21.0 (15.4, 24.3)","13.9 (9.2, 18.7)","2.9 (1.8, 4.7)","20.4 (14.6, 24.1)","-23.1% (-43.6%, -5.6%)","17.1% (6.7%, 33.5%)","-23.8% (-46.0%, -6.3%)","-29.1% (-59.5%, -3.1%)","18.6% (7.4%, 35.6%)"
